The stock of Wave Life Sciences Ltd. (WVE) is down >50% so far today, trading at a value of ~$6 at the time of writing (market cap of $1.2bn), after the Singapore-headquartered biotech reported ...

In that future, the central challenge for humans may become something deeper. Recognition and self-actualization could arise ...

The number and variety of test interfaces, coupled with increased packaging complexity, are adding a slew of new challenges.

The construction industry, which has historically been perceived as being hesitant to adopt new technologies, is going through a ...

Vintage rookie autograph cards are gaining attention, but some still feel underpriced. Here are five that stand out based on ...

Large sums of money were spent trying to build a spy drone just like the RQ-180 for a very specific mission decades beforehand.

True crime has quietly become one of the most dominant forces in modern entertainment. A YouGov poll found that 57% of ...

Discover the terrifying truths hiding in plain sight, from our own mortality to societal exploitation. Uncover the unseen ...

Wave Life Sciences (WVE) fell ~57% in the premarket on Thursday as Wall Street reacted to interim data from an early-stage trial for WVE-007, its RNA-based obesity medicine. Citing six-month follow-up ...

Wave Life Sciences (WVE) shares fell nearly 50% to $6.20 after BofA and Wells Fargo cut price targets to $21 and $13 respectively, citing insufficient data for WVE-007 as a standalone obesity ...

A soaring cosmic symphony surrounds us; its notes emerge from massive celestial objects crashing together hundreds of millions or even billions of light-years away. But scientists have only tuned into ...

A Majorana fermion is a particle that would be identical to its antiparticle. Such an object has not yet been found. However, ...